Skip to content
Catalyst

melatoninFinding

Melatonin has no detected effect on Psoriasis Area and Severity Index (PASI) score

no difference foundModerate evidenceFinding

01 · The sentence it was drawn from

“Although the PASI score in the melatonin and rosuvastatin groups compared with placebo decreased, the changes were not significant.”
Quoted verbatim from Efficacy and safety of topical rosuvastatin & melatonin vs. placebo in patients with mild to moderate plaque psoriasis: A preliminary randomized double-blinded clinical trial.
This finding among the 2 findings on its endpoint

melatonin

Psoriasis Area and Severity Index (PASI) score

no difference found

Who
adults with mild-to-moderate plaque psoriasis; melatonin cream 5% w/w vs placebo cream, applied twice daily for 8 weeks
Dose studied
melatonin cream 5.0% (w/w) applied twice a day

Moderate evidencePMID 38563131 · 2024

02 · The study

Study
RCT
Duration
not reported

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M3R5A77BJRTPZNGCPA2MJKTM